SELB Selecta Biosciences Inc

Selecta Biosciences Inc is a clinical-stage biopharmaceutical company using its proprietary synthetic vaccine particle technology to discover & develop targeted therapies designed to modulate the immune system to treat rare and serious diseases.

$4.56  -0.27 (-5.50%)
As of 06/22/2021 15:59:54 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/22/2016
Outstanding shares:  113,193,597
Average volume:  1,756,097
Market cap:   $532,009,906
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    816212104
ISIN:        US8162121045
Sedol:      BZB1WS8
Valuation   (See tab for details)
PE ratio:   -10.96
PB ratio:   49.69
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy